首页> 外国专利> METHOD FOR SELECTING THE APPROACH TO OPEN-HEART SURGICAL INTERVENTION APPLYING HEMOTRANSFUSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE

METHOD FOR SELECTING THE APPROACH TO OPEN-HEART SURGICAL INTERVENTION APPLYING HEMOTRANSFUSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE

机译:选择慢性肾疾病患者血液转化血液转化术的方法选择方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely, to cardiac surgery, vascular surgery. The level of haptoglobin in the blood serum is determined presurgically, and if the value thereof is less than 1.5 mg/l, a blood-saving surgical intervention with maximum prevention of hemolysis is selected. The indicators of free hemoglobin are therein additionally determined intrasurgically in the blood serum and in each dose of the erythrocyte suspension prior to hemotransfusion, and restrictive hemotransfusion is applied if the level of free hemoglobin in the blood serum and/or in the erythrocyte suspension is greater than 1 g/dl.;EFFECT: method provides a possibility of preventing excessive toxic effect of free hemoglobin on the structures of the nephron in surgical interventions associated with hemolysis or significant blood loss, reducing the risks of acute kidney damage in patients with chronic kidney disease.;1 cl, 1 ex
机译:田地:医学。物质:发明涉及药物,即心脏手术,血管手术。 血液血清中的抗oglobin水平是预先确定的,并且如果其值小于1.5mg / L,则选择最大预防溶血的节水手术干预。 在其中,在血液血清中另外,在血液血清中另外测定自由血红蛋白的指标,并且在血液过量灌注之前的每种剂量的红细胞悬浮液中,并且如果血液血清中的游离血红蛋白水平和/或红细胞悬浮液更大,则施加限制性血红蛋白 比1g / dl。;效果:方法提供了防止游离血红蛋白对与溶血或显着的血液损失相关的外科干预患者结构的过度毒性作用,从而降低慢性肾脏患者急性肾脏损伤的风险 疾病。; 1 cl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号